spiroxatrine (Compound)

Synonyms:Spiroxatrine, 1054-88-2, Spiroxatrine (R 5188), R 5188, Spiroxatrine [INN], Spiroxatrinum, SPIROXAMIDE, 8-[(2,3-Dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one, DR0QR50ALL, NSC-665322, CHEMBL300555, DTXSID3045198, NSC665322, NCGC00015908-05, R-5188, DTXCID1025198, Espiroxatrina, Spiroxatrinum [INN-Latin], 8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, Espiroxatrina [INN-Spanish], CAS-1054-88-2, SR-01000075579, UNII-DR0QR50ALL, NSC 665322, Biomol-NT_000104, GTPL53, Lopac0_001142, BPBio1_001395, SCHEMBL1255303, SCHEMBL23326247, CHEBI:91845, HMS2089G17, HMS3263F05, HMS3266D15, HMS3411K18, HMS3675K18, Tox21_110260, Tox21_501142, BDBM50020192, AKOS024458589, Tox21_110260_1, CCG-205216, LP01142, SDCCGSBI-0051109.P002, 1,3,8-Trianaspiro(4.5)decane-4-one,8-(1,4-benzodioxan-2-ylmethyl)-1-phenyl-, 8-(1,4-Benzodioxan-2-ylmethyl)-1-phenyl-1,3,8-trianaspiro(4,5)decane-4-one, 8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one, NCGC00015908-03, NCGC00015908-04, NCGC00015908-06, NCGC00015908-07, NCGC00015908-08, NCGC00015908-09, NCGC00024696-02, NCGC00024696-03, NCGC00024696-04, NCGC00024696-05, NCGC00261827-01, NCI60_022532, DB-108293, EU-0101142, S-103, L001271, J-001433, Q6592066, SR-01000075579-1, SR-01000075579-3, BRD-A72483914-001-01-1, BRD-A72483914-001-02-9, 8-(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, 8-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Pubchem:PUBCHEM:5268

Id:195177cf-6087-5b9e-b929-9e73765d1292

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View spiroxatrine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for spiroxatrine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with spiroxatrine.

Results found

Linked to

	Label	Description
	BRD-A72483914-001-02-9 Substance (Entity type)	A Substance
	spiroxatrine (9dc44501-82f3-409f-b62c-b01dda6bbd5d) Collection (Entity type)	Metadatata for spiroxatrine
	spiroxatrine positively regulates NFATC3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine negatively regulates AQP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine negatively regulates OLFM4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine bioactivity Alpha-2B adrenergic receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	spiroxatrine negatively regulates ZNF586 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine positively regulates CITED2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine positively regulates MARCKS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	spiroxatrine negatively regulates ATP6V1D Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS